Vaccinex, Inc. (VCNX) Net margin 2017–2024
Vaccinex, Inc. (VCNX) net profit margin by fiscal year — reported net income divided by reported revenue.
-3100.5%FY2024 · since FY2017: -20802.2% → -3100.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -3100.5% | +452.3 pp |
| FY2023 | -3552.8% | +3652.6 pp |
| FY2022 | -7205.5% | -4718.8 pp |
| FY2021 | -2486.7% | +2129.5 pp |
| FY2020 | -4616.2% | +1476.2 pp |
| FY2019 | -6092.4% | -2015.3 pp |
| FY2018 | -4077.1% | +16725.2 pp |
| FY2017 | -20802.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More VCNX financial trends
VCNX RevenueVCNX Net incomeVCNX Gross profitVCNX Gross marginVCNX Operating incomeVCNX Operating marginVCNX Operating cash flowVCNX Free cash flowVCNX Capital expendituresVCNX Return on equityVCNX Stock buybacksVCNX Dividends paidVCNX Total assetsVCNX Total liabilitiesVCNX Shareholders’ equityVCNX overview →